Recent advances in developing neuroprotective strategies for perinatal asphyxia

Current Opinion in Pediatrics

Volumn 10, Issue 6, 1998, Pages 575-580

  Robertson, Nicola J ^a   Edwards, A David ^a  

^a Hammersmith Campus   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; DIZOCILPINE; GLUTAMIC ACID; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; OXIPURINOL; OXYGEN RADICAL; POLY(ADENOSINE DIPHOSPHATE RIBOSE); SOMATOMEDIN; XANTHINE OXIDASE INHIBITOR;

APOPTOSIS; BIRTH; BRAIN INJURY; CELL DEATH; HUMAN; INDUCED HYPOTHERMIA; LAMB; MOUSE; NERVOUS SYSTEM INJURY; NEUROTOXICITY; NEWBORN; NONHUMAN; PERINATAL ASPHYXIA; PRIORITY JOURNAL; RAT; REPERFUSION; RESUSCITATION; REVIEW; SHEEP; SWINE;

EID: 0031723358     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199810060-00006     Document Type: Review

References (82)

1. Rutherford MA, Pennock JM, Schweiso J, Cowan F, Dubowitz L: Hypoxicischaemic encephalopathy: early and late magnetic resonance imaging findings in relation to outcome. Arch Dis Child 1996, 75:F145-F151.
2. Rutherford MA, Pennock J, Counsell S, Mercuri E, Cowan FM, Dubowitz LMS, Edwards AD: Abnormal magnetic resonance signal in the internal capsule predicts poor outcome in infants with hypoxic-ischaemic encephalopathy. Pediatrics 1998, in press. An abnormal signal intensity in the posterior limb of the internal capsule on magnetic resonance imaging between days 1 and 17 was found to be an extremely accurate predictor of neurodevelopmental outcome at 1 year of age in 73 term infants with hypoxic-ischemic encephalopathy.
3. Gunn AJ, Parer JT, Mallard EC, Williams CE, Gluckman PD: Cerebral histologic and electrocorticographic changes after asphyxia in fetal sheep. Pediatr Res 1992, 31:486-491.
4. Lorek A, Takei Y, Cady EB, Wyatt JS, Penrice J, Edwards AD, et al.: Delayed "secondary" cerebral energy failure following acute hypoxiaischemia in the newborn piglet: continuous 48-hour studies by 31P magnetic resonance spectroscopy. Pediatr Res 1994, 36:699-706.
5. Grether JK, Nelson KB: Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997, 278:207-211. In this population-based case control study, maternal fever exceeding 38°C in labor was associated with increased risk of unexplained cerebral palsy (odds ratio, 9.3) as was a clinical diagnosis of chorioamnionitis. Maternal fever was also linked with low Apgar scores, need for resuscitation and neonatal seizures.
6. Dammann O, Leviton A: Maternal intrauterine infection, cytokines and brain damage in the preterm newborn. Pediatr Res 1997, 42:1-8. This review of the epidemiologic and laboratory literature suggests a link between prenatal intrauterine infection, proinflammatory cytokines, interleukin-1, interleukin-6 and tumor necrosis factor and neonatal brain damage.
7. Kirino T: Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1997, 239:57-69.
8. Wyatt JS, Edwards AD, Azzopardi D, Reynolds EOR: Magnetic resonance and near infrared spectroscopy for investigation of perinatal hypoxic-ischaemic brain injury. Arch Dis Child 1989, 64:953-963.
9. Mies G, Paschen W, Hossmann K-A: Cerebral blood flow, glucose utilisation, regional glucose, and ATP content during the maturation period of delayed ischaemic injury in gerbil brain. J Cereb Blood Flow Metab 1990, 10:638-645.
10. Roth SC, Baudin J, Cady E, Johal K, Townsend JP, Wyatt JS, et al.: Relation of deranged neonatal cerebral oxidative metabolism with neurodevelopmental outcome and head circumference at 4 years. Dev Med Child Neurol 1997, 39:718-725.
11. Hanrahan D, Sargentoni J, Cox IJ, Bell JD, Bryant DJ, Cowan FM, et al.: Persistent increases in cerebral lactate concentration after birth asphyxia. Pediatr Res 1998, in press.
12. Robertson NJ, Cox IJ, Counsell JJ, Azzopardi D, Edwards AD, et al.: Persistent lactate following perinatal hypoxic-ischaemic encephalopathy and its relationship to energy failure studied by magnetic resonance spectroscopy. Early Hum Dev 1998, 5:73.
13. Edwards AD, Yue X, Cox P, Hope PL, Azzopardi D, Squier MV, Mehmet H: Apoptosis in the brains of infants suffering intrauterine cerebral injury. Pediatr Res 1997, 42:684-698.
14. Scott RJ, Hegyi L: Cell death in perinatal hypoxic-ischaemic brain injury. Neuropathol Appl Neurobiol 1997, 23:315-321.
15. Mazarakis ND, Edwards AD, Mehmet H: Apoptosis in neural development and disease. Arch Dis Child 1997, 75:F73-F75.
16. Du C, Hu R, Csernansky CA, Hsu CY, Choi DW: Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab 1996, 16:195-201,
17. Gluckman PD, Williams CE: When and why do brain cells die? Dev Med Child Neurol 1992, 34:1010-1014.
18. Szatkowski M, Attwell D: Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci 1994, 17:359-365.
19. McDonald JW, Silverstein FS, Cardona D, Hudson C, Chen R, Johnston MV: Systemic administration of MK-801 protects against N-methyl-D-aspartate and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience 1990, 36:589-599.
20. Hattori H, Morin A, Schwartz P, Fujikawa DG, Wasterlain CG, et al.: Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology 1989, 39:713-718.
21. McDonald JW, Silverstein FS, Johnston MV: MK-801 protects the neonatal brain from hypoxic-ischaemic damage. Eur J Pharmacol 1994, 140:359-361.
22. Tan WK, Williams CE, Gunn AJ, Mallard CE, Gluckman PD: Suppression of postischemic epileptrform activity with MK-801 improves neural outcome in fetal sheep. Ann Neurol 1992, 32:677-682.
23. McAuley MA: Rodent models of focal ischaemia. Cerebrovasc Brain Metab Rev 1995, 7:153-180.
24. Morin AM, Hattori H, Wasterlain CG, Thomson D: [3H]MK-801 binding sites in neonate rat brain. Brain Res 1989, 487:376-379.
25. Small DL, Buchan AM: NMDA antagonists:their role in neuroprotection. Int Rev Neurobiol 1997, 40:137-171.
26. McDonald JW, Silverstein FS, Johnston MV: Magnesium reduces N-methyf-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett 1990, 109:234-238.
27. Marret S, Gressens P, Gadisseux JF, Evrard P: Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol 1995, 37:473-484.
28. de Haan HH, Gunn AJ, Williams CE, Heymann MA, Gluckman PD: Magnesium sulfate therapy during asphyxia in near term fetal lambs does not compromise the fetus but does not reduce cerebral injury. Am J Obstet Gynecol 1997, 176:18-27.
29. Penrice J, Amess P, Punwani S, Wylezinska M, Tyszczuk L, D'Souza P, et al.: Magnesium sulphate after transient hypoxia-ischemia fails to prevent delayed cerebral energy failure in the newborn piglet. Pediatr Res 1997, 41:443-449.
30. Nelson KB, Grether JK: Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995, 95:263-269.
31. Mittendort R, Covert R, Boman J, Khoshnood B, Lee KS, Siegler M: Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet 1997, 350:1517-1519.
32. Bennett P, Edwards AD: Use of magnesium sulphate in obstetrics [letter]. Lancet 1997, 350:1491.
33. Benichou J, Zupan V, Fernandez H, Marpeau L, Marret S: Tocolytic magnesium sulphate and paediatric mortality. Lancet 1997, 351:290-291.
34. Dalkara T, Moskowitz MA: The complex role of nitric oxide in the pathophysiology of focal cerebral ischaemia. Brain Pathol 1994, 4:49-57.
35. Gaston B, Drazen JM, Loscalzo J, Stamler JS: The biology of nitrogen oxides in the airways. Am Rev Respir Dis 1994, 149:538-551.
36. Lowenstein CJ, Dinerman JL, Snyder SH: Nitric oxide: a physiologic messenger. Ann Intern Med 1994, 120:227-237.
37. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P: Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15:961-973.
38. Khan S, Kayahara M, Joashi U, Mazarakis ND, Sarraf C, Edwards AD, et al.: Differential induction of apoptosis in Swiss 3T3 cells by nitric oxide and nitrosonium cation. J Cell Sci 1997, 110:2315-2322.
39. Tan WK, Williams CE, During MJ, Mallard CE, Gunning MI, Gunn AJ, Gluckman PD: Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischaemic injury in late gestation fetal sheep. Pediatr Res 1996, 39:791-797.
40. Thoresen M, Satas S, Puka-Sundvall M, Whitelaw A, Hallestrom A, Loberg E, et al.: Post-hypoxic hypothermia reduces cerebrocortical release of NO and excitotoxins. Neuroreport 1997, 8:3359-3362.
41. Marks KA, Mallard C, Roberts I, Williams C, Gluckman P, Edwards AD: Nitric oxide synthase inhibition attenuates delayed vasodilation and increases injury following cerebral ischaemia in fetal sheep. Pediatr Res 1996, 40:185-191.
42. Ferriero DM, Holtzman DM, Black SM, Sheldon RA: Neonatal mice lacking neuronal nitric oxide synthetase are less vulnerable to hypoxic-ischaemic injury. Neurobiol Dis 1996, 3:64-71.
43. McCord JM: Oxygen derived free radicals in postischaemic tissue injury. N Engl J Med 1985, 312:159-63.
44. Palmer C: Hypoxic-ischaemic encephalopathy:therapeutic approaches against microvascular injury, and role of neutrophils, PAF and free radicals. Clin Perinatol 1995, 22:481-517.
45. Takashima S: Immunohistochemistry of superoxide dismutase-1 in developing human brain. Brain Dev 1990, 12:211-213.
46. 31P NMR study in unanesthetized immature rats. Neurosci Lett 1992, 144:103-106.
47. Palmer C, Vannucci RC, Towfighi J: Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 1990, 27:332-336.
48. Palmer C, Smith MB, Williams GD: Alloprinol preserves cerebral energy metabolism during perinatal hypoxic-ischaemic injury and reduces brain damage in a dose dependent manner. J Cereb Blood Flow Metab 1991, 11(suppl):S144-S149.
49. Moorhouse PC, Grootveld M, Halliwell B, Quinlan JC, Gutteridge JMC: Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 1987, 21:23-28.
50. Ko KM, Godin DV: Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem Pharmacol 1990, 40:803-809.
51. Boda D, Nemeth I, Hencz P, Denes K: Effect of allopurinol treatment in premature infants with idiopathic respiratory distress syndrome. Dev Pharmacol Ther 1984, 7:357-367.
52. Russell GA, Cooke RW: Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child 1995, 73:F27-F31.
53. Marro PJ, Baumgart S, Delivora-Papadopoulos M, Zirin S, Corcoran L, Philips McGaum S, et al.: Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation. Pediatr Res 1997, 41:513-520.
54. Van Bel F, Shadid M, Moison RMW, Dorrepaal CA, Fontijn J, Monteiro L, et al.: Effect of allopurinol on postasphyxial free radical formation, cerebral haemodynamics and electrical brain activity. Pediatrics 1998, 101:185-193. The effect of high-dose allopurinol (40 mg/kg) was assessed on cerebral perfusion, free radical formation and electrical brain activity in 22 severely asphyxiated newborns. Cerebral perfusion was investigated using near infrared spectroscopy, free radical formation by plasma non-protein-bound iron, antioxidant capacity and malondialdehyde and electrical activity by the cerebral function monitor. This pilot study suggested a benefit in these factors without toxic side-effects.
55. Beilharz E, Williams CE, Dragunow M, Sirimanne E, Gluckman PD: Mechanisms of cell death following hypoxic-ischaemic injury in the immature rat: evidence of apoptosis during selective neuronal loss. Mol Brain Res 1995, 29:1-14.
56. Dragnow M, Beilharz E, Sirimanne E: Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury in the young rat brain. Mol Brain Res 1994, 25:19-33.
57. Mehmet H, Yue X, Squier MV, Lorek A, Cady E, Penrice J, et al.: Increased apoptosis in the cingulate sulcus of newborn piglets following transient hypoxia-ischaemia is related to the degree of high energy phosphate depletion during the insult. Neurosci Lett 1994, 181:121-125.
58. Evan GI: Old cells never die, they just apoptose. Trends Cell Biol 1994, 4:191-192.
59. Martinou JC, Dubois Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, et al.: Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994, 13:1017-1030.
60. Lawrence MS, Ho DY, Sun GH, Steinberg GK, Salpolsky RM: Over-expression of bcl-2 with herpes simplex virus vectors protects central neurons against neurological insults in vitro and in vivo. J Neurosci 1996, 15:486-496.
61. Mehmet H, Yue X, Penrice J, Cady EB, Wyatt JS, Sarraf CE, et al.: Relation of impaired energy metabolism to apoptosis and necrosis following transient cerebral hypoxia-ischaemia in the newborn piglet. Cell Death Differ 1997, 5:321-329.
62. Jeggo PA: DNA repair: PARP-another guardian angel? Curr Biol 1998, 8:R49-R51.
63. Takahashi K, Greenberg JH, Jackson P, Maclin K, Zhang J: Neuroprotective effects of inhibiting Poly(ADP-ribose) Synthetase on focal cerebral ischaemia in rats. J Cereb Blood Row Metab 1997, 17:1137-1142. This study demonstrates for the first time that in vivo administration of a potent PARP inhibitor led to a significant reduction of infarct volume in a focal cerebral ischemia model in the rat.
64. Eliasson MJL, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, et al.: Poly(ADP) ribose polymerase gene disruption renders mice resistant to cerebral ischaemia. Nature Med 1997, 3:1089-1095. It is demonstrated that genetic disruption of PARP provides profound protection against glutamate-NO-mediated ischemic insults in vitro and major decreases in infarct volume after reversible middle cerebral artery occlusion in mice. These results give evidence for a primary involvement of PARP activation in neuronal damage following focal ischemia.
65. Nieto-Sampedro M, Lewis ER, Cotman CW, Manthorpe M, Skaper SD, Barbin G, et al.: Brain injury causes a time-dependent increase in neurotrophic activity at the lesion site. Science 1982, 217:860-861.
66. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC: Cell death in the oligodendrocyte lineage. J Neurobiol 1992, 23:1221-1230.
67. Guan J, Williams C, Gunning M, Mallard C, Gluckman P: The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. J Cereb Blood Flow Metab 1993, 13:609-616.
68. Gluckman PD, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M, et al.: A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun 1992, 182:593-599.
69. Johnston BM, Mallard EC, Williams CE, Gluckman PD: Insulin-like growth factor-1 is a potent neuronal rescue agent hypoxic-ischemic injury in fetal lambs. J Clin Invest 1996, 97:300-308.
70. Holtzman DM, Sheldon RA, Wyatt J, Cheng Y, Ferriero D: Nerve growth factor protects the neonatal brain against hypoxic-ischaemic injury. Ann Neurol 1996, 39:114-122.
71. Thoresen M, Bagenholm R, Loberg EM, Apricena F, Kjellmer I: Posthypoxic cooling of neonatal rats provides protection against brain injury. Arch Dis Child 1996, 74:F3-F9.
72. Bona E, Loberg E, Bagenholm R, Hagberg H, Thoresen M, et al.: Protective effects of moderate hypothermia after hypoxia-ischaemia in a neonatal rat model: short and long-term outcome [abstract]. J Cereb Blood Flow Metab 1997, 17(suppl 1):S857.
73. Bona E, Hagberg H, Loberg E, Bagenholm R, Thoresen M: Protective effects of moderate hypothermia after neonatal hyoxia-ischaemia:short and long term outcome. Pediatr Res 1998, 43:738-745.
74. Sirimanne E, Blumberg RM, Bossano D, Gunning M, Edwards AD, Gluckman PD, Williams CE: The effect of prolonged modification of cerebral temperature on outcome following hypoxic-ischaemic brain injury in the infant rat. Pediatr Res 1996, 39:591-597.
75. Thoresen M, Penrice J, Lorek A, Cady E, Wylezinska M, Kirkbride V, et al.: Mild Hypothermia following severe transient hypoxia-ischaemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res 1995, 37:667-670.
76. Edwards AD, Yue X, Squier MV, Thoresen M, Cady EB, Penrice J, et al.: Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia. Biochem Biophys Res Commun 1995, 217:1193-1199.
77. Gunn AJ, Gunn TR, De Haan HH, Williams CE, Gluckman PD: Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest 1997, 99:248-256. Head cooling for 72 hours in the fetal sheep and begun up to 5 hours after HI was seen to reduce secondary cortical cytotoxic oedema, improve the electroencephalogram and reduce the extent of cortical infarction and neuronal loss in all regions examined.
78. Gunn TR, Gunn AJ, Gluckman PD: Substantial neuronal rescue with prolonged selective head cooling begun 5.5 hours after cerebral ischaemia in fetal sheep [abstract]. Pediatr Res 1997, 41:152.
79. Towfighi J, Housman C, Heitjan DF, Vannucci RC, Yager JY: The effect of focal cerebral cooling on perinatal hypoxic-ischemic brain damage. Acta Neuropathol Berl 1994, 87:598-604.
80. Bernard SA, Jones BM, Horne MK: Clinical trial of induced hypothermia in comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med 1997, 30:146-753.
81. Marion DW, Penrod LE, Kelsey SF, Obrist WD, Kochanek PM, Palmer AM, et al.: Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997, 336:540-546. In a randomized controlled trial the authors compared the effects of moderate hypothermia and normothermia on 82 patients with severe closed head injuries. The patients assigned to hypothermia were cooled to 33°C at a mean of 10 hours after the injury, kept at 32°C to 33°C for 24 hours and then rewarmed. Hypothermia did not improve the outcome of patients with coma scores of 3 or 4 on admission; however, in those with coma scores of 5 to 7 on admission, hypothermia hastened neurologic recovery and may have improved the outcome
82. Amess PN, Penrice J, Lorek A, Wylezinska M, Cooper CE, D'Souza P, et al.: Mild hypothermia after transient hypoxia-ischemia reduces the delayed rise in cerebral lactate in the newborn piglet. Pediatr Res 1997, 41:803-808.